Tevogen Bio Holdings Inc. (TVGN)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20263 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Tevogen Bio Holdings Inc.’s names, not what it holds today.
0 published
3 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jan 11, 2022 | 11,219,684 | COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19 | Pharmaceuticals | Tevogen Bio Inc. |
| Dec 28, 2021 | 11,207,401 | COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19 | Pharmaceuticals | Tevogen Bio Inc. |
| Dec 7, 2021 | 11,191,827 | COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19 | Pharmaceuticals | Tevogen Bio Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Oct 31, 2024 | 2024/0358753 | METHODS FOR DEVELOPING CD3+CD8+ CELLS AGAINST MULTIPLE VIRAL EPITOPES FOR TREATMENT OF VIRAL INFECTIONS INCLUDING VARIANTS EVOLVING TO ESCAPE PREVIOUS IMMUNITY | Pharmaceuticals | Tevogen Bio Inc. |
| Nov 23, 2023 | 2023/0372398 | VIRUS SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING VIRAL INFECTIONS | Medical technology | Tevogen Bio Inc. |
| Jun 30, 2022 | 2022/0202865 | VIRUS SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING VIRAL INFECTIONS | Medical technology | Tevogen Bio Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.